Alberta Regulation 180/2018

Gaming, Liquor and Cannabis Act

GAMING, LIQUOR AND CANNABIS AMENDMENT REGULATION

Filed: October 18, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 300/2018)

on October 17, 2018 pursuant to

section 129 of the Gaming, Liquor and Cannabis Act.

1 The Gaming, Liquor and Cannabis Regulation

(AR 143/96) is amended by this Regulation.

Section 1(1)(h.1) is repealed.

Section 19(

c) is amended by striking out "or prize bonds".

Section 24(

a) and (

b) are repealed and the following is

substituted:

(

a) a person who is paid to sell pull tickets or raffle tickets;

(

b) a person who is paid to perform a function in respect of a

raffle where the authorized ticket value is $20 000 or less;

Section 25(

d) is repealed and the following is

substituted:

(

d) raffle worker: authorizes a person to perform a function

specified in the person's registration in respect of a raffle

where the authorized ticket value exceeds $20 000;

Section 28(1)(

d) is repealed and the following is

substituted:

(

d) raffle worker registrations;

Section 39 is repealed and the following is substituted:

Licensed premises

39 The licensed premises under a Class B liquor licence must be

(

a) a recreational facility, tourist facility, race track, sports

stadium, convention centre, theatre or public conveyance in

which entrance is restricted to persons who purchase a ticket

or pay a user fee or on some other basis acceptable to the

board, or

(

b) a premises where a business is being operated that

(

i) offers goods or services for sale to members of the

public,

(ii) does not have as a primary purpose the sale or provision

of food or beverages, and

(iii) is in a class of business approved by the board.

Section 47(d)(iii) is amended by striking out "subject to

section 53,".

9 The following is added after

section 58:

Class F Liquor Licences

Class F liquor licence

58.1 A Class F liquor licence authorizes the licensee, in

accordance with board policy,

(

a) to permit adults to make wine, cider or beer up to the

quantity approved by the board in the licensed premises as

provided for in

section 86 of the Act,

(

b) to charge a fee for permitting adults to make and store wine,

cider or beer in the licensed premises, and

(

c) to store the wine, cider or beer made by the adults in the

licensed premises.

Section 68 is amended

(

a) by repealing subsection (2) and substituting the

following:

(2) A liquor licensee may, if authorized under

section 67.1,

serve for consumption in licensed premises wine dispensed only

from the original container used to hold the wine taken into the

licensed premises by a patron.

(

b) by repealing subsection (5) and substituting the

following:

(5) Liquor from one container may not be mixed with liquor

from another container unless

(

a) the liquor is mixed at the request of a patron and served

to the patron in a glass or other container satisfactory to

the board,

(

b) the liquor is liquor from one container, as shipped by

the distributor, of a particular brand poured into another

size container of the same brand, as shipped by the

distributor, or

(

c) the mixing of the liquor is permitted under board

policies.

Section 83(2) is amended by striking out "Class A," and

substituting "Class".

12 The following is added after

section 97:

Residential facility for adults

97.1(1) If permitted by the owner or operator of an institution that

is a residential facility for adults, an adult who resides in the

residential facility may consume liquor in the common areas of the

residential facility.

(2) If permitted by the owner or operator of an institution that is a

residential facility for adults, an adult who resides in the residential

facility may provide liquor from the adult's residence within the

residential facility to the adult's guests and the guests may consume

the liquor in the common areas of the residential facility.

Schedule 1 is amended

(

a) in

section 1

(

i) in clause (

a) by striking out "$30" and

substituting "$20";

(ii) in clause (

b) by striking out "$10" and

substituting "$5";

(iii) in clause (c)

(

A) in the portion preceding subclause (

i) by

striking out "total ticket sales" and

substituting "the authorized ticket value";

(

B) in subclauses (

i) and (ii) by striking out

"$10 000" and substituting "$20 000".

(iv) by repealing clause (c.1);

(

b) by adding the following after

section 8:

8.1

Class F liquor licence

$500

Schedule 3 is amended in

Part 1 in

section 1(

f) by

striking out "until final curtain, but subject to the hours set out in

clause (a)" and substituting ", but not before 10:00 a.m., until 2:00

a.m.".

15 Sections 4, 5, 6 and 13(a)(i), (ii) and (iii) come into force

on December 1, 2018.

--------------------------------

Alberta Regulation 181/2018

Missing Persons Act

MISSING PERSONS AMENDMENT REGULATION

Filed: October 18, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 301/2018)

on October 17, 2018 pursuant to

section 14 of the Missing Persons Act.

1 The Missing Persons Regulation (AR 151/2012) is

amended by this Regulation.

Section 9 is amended by striking out "November 30, 2018"

and substituting "November 30, 2021".

Alberta Regulation 182/2018

Public Health Act

IMMUNIZATION REGULATION

Filed: October 18, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 306/2018)

on October 17, 2018 pursuant to

section 66 of the Public Health Act.

Table of Contents

Interpretation

Part 1

Assessment and Immunization Reporting

2 Assessment reporting

3 Immunization reporting

4 Reporting re past unreported immunization

Part 2

Reporting of Adverse Event

Following Immunization

5 Health practitioner reporting re adverse

event following immunization

6 Regional health authority reporting re adverse

event following immunization

Part 3

Maintenance of Vaccine Viability

Interpretation

8 Transportation requirements

9 Storage requirements

10 Handling requirements

11 Action following contravention of

temperature conditions

12 Action after quarantine

13 Record keeping re temperature

conditions contravention

14 Coming into force

Schedule

Interpretation

1(1) In this Regulation, "Act" means the Public Health Act.

(2) For the purposes of this Regulation and

section 18.4 of the Act,

"adverse event following immunization" means an unfavourable health

occurrence experienced by a patient that

(

a) follows immunization,

(

b) cannot be attributed to a pre-existing condition, and

(

c) meets one or more of the following criteria, as determined by

a health practitioner:

(

i) the health occurrence is life-threatening, could result in

permanent disability, requires hospitalization or urgent

medical attention, or for any other reason is considered

to be of a serious nature;

(ii) the health occurrence is unusual or unexpected,

including, without limitation, an occurrence that

(

A) has not previously been identified, or

(

B) has previously been identified but is being reported

at increased frequency;

(iii) the health occurrence cannot be explained by anything

in the patient's medical history, including, without

limitation, a recent disease or illness, or consumption of

medication.

Part 1

Assessment and

Immunization Reporting

Assessment reporting

2(1) A health practitioner who conducts an assessment with the

intention of immunizing the patient following the assessment shall

ensure that a report is submitted to the Chief Medical Officer

respecting the assessment if either of the following conditions exist:

(

a) the health practitioner recommends immunization but does

not receive consent for the immunization;

(

b) the health practitioner determines that immunization is

contraindicated.

(2) The health practitioner shall ensure that the report respecting the

assessment is submitted by electronic means specified by the Chief

Medical Officer as soon as possible and no later than 7 days after the

assessment.

(3) The report respecting the assessment must contain the following

information:

(

a) patient first name and last name;

(

b) patient personal health number or unique lifetime identifier;

(

c) patient date of birth;

(

d) patient sex at birth;

(

e) vaccine code for the intended immunization;

(

f) antigen code for the intended immunization;

(

g) delivery management site code;

(

h) date of the assessment;

(

i) reason the vaccine was not administered.

Immunization reporting

3(1) A health practitioner who immunizes a patient shall ensure that a

report respecting the immunization is submitted to the Chief Medical

Officer by electronic means specified by the Chief Medical Officer.

(2) The health practitioner shall ensure that the report respecting the

immunization is submitted as soon as possible and no later than 7 days

after the immunization.

(3) The report respecting the immunization must contain the following

information:

(

a) patient first name and last name;

(

b) patient personal health number or unique lifetime identifier;

(

c) patient date of birth;

(

d) patient sex at birth;

(

e) vaccine code for the immunization;

(

f) antigen code for the immunization;

(

g) antigen dose count for the immunization;

(

h) lot number of the vaccine, if available;

(

i) manufacturer of the vaccine;

(

j) date of the immunization;

(

k) delivery management site code;

(

l) reason the vaccine was administered.

Reporting re past unreported immunization

4(1) A health practitioner who, in the course of an immunization or an

assessment conducted with the intention of immunizing the patient

following the assessment, receives a complete written record

respecting a past unreported immunization shall ensure that a report

respecting the past unreported immunization is submitted to the Chief

Medical Officer by electronic means specified by the Chief Medical

Officer.

(2) The health practitioner shall ensure that the report respecting the

past unreported immunization is submitted as soon as possible and no

later than 7 days after the health practitioner receives the written record

respecting the past unreported immunization.

(3) The report respecting the past unreported immunization must

contain the following information:

(

a) patient first name and last name;

(

b) patient personal health number or unique lifetime identifier;

(

c) patient date of birth;

(

d) patient sex at birth;

(

e) vaccine code for the immunization;

(

f) antigen code for the immunization;

(

g) antigen dose count, if available;

(

h) lot number of the vaccine, if available;

(

i) manufacturer of the vaccine, if available;

(

j) date of the immunization;

(

k) delivery management site code for the immunization, if

available;

(

l) reason the vaccine was administered, if available.

Part 2

Reporting of Adverse Event

Following Immunization

Health practitioner reporting re adverse

event following immunization

5(1) A health practitioner shall ensure that an adverse event following

immunization is reported to a regional health authority within 3 days of

the health practitioner determining or being informed that a patient of

the health practitioner has experienced an adverse event following

immunization that has not been reported to a regional health authority.

(2) The health practitioner shall ensure that the adverse event

following immunization is reported by a method of immediate

transmission, including, without limitation, telephone, facsimile or

e-mail.

(3) The following information must be reported in respect of the

adverse event following immunization:

(

a) patient first name and last name;

(

b) patient personal health number or unique lifetime identifier;

(

c) patient date of birth;

(

d) patient sex at birth;

(

e) description of the adverse event, including, without

limitation, any applicable symptom or diagnosis listed in the

Schedule as reported by the patient or observed or diagnosed

by the health practitioner, as the case may be, and the onset

and duration of the adverse event;

(

f) vaccine code of the vaccine used in the immunization

preceding the adverse event following immunization, if

available;

(

g) lot number of the vaccine used in the immunization

preceding the adverse event following immunization, if

available;

(

h) manufacturer of the vaccine used in the immunization

preceding the adverse event following immunization, if

available;

(

i) date of the immunization preceding the adverse event

following immunization;

(

j) delivery management site code for the immunization

preceding the adverse event following immunization, if

available;

(

k) first name, last name and telephone number of the person

reporting.

Regional health authority reporting re adverse

event following immunization

6(1) Within 4 days of determining that a patient has experienced an

adverse event following immunization that is listed in the Schedule, a

regional health authority shall submit a report respecting the adverse

event following immunization to the Chief Medical Officer by

electronic means specified by the Chief Medical Officer.

(2) The report of the regional health authority in respect of an adverse

event following immunization must contain the following information:

(

a) patient first name and last name;

(

b) patient personal health number or unique lifetime identifier;

(

c) patient date of birth;

(

d) patient sex at birth;

(

e) vaccine code of the vaccine used in the immunization

preceding the adverse event following immunization;

(

f) lot number of the vaccine used in the immunization

preceding the adverse event following immunization, if

available;

(

g) manufacturer of the vaccine used in the immunization

preceding the adverse event following immunization, if

available;

(

h) date of the immunization preceding the adverse event

following immunization;

(

i) recommendation, if any, provided by the regional health

authority in respect of a patient's future immunization or in

respect of follow-up action;

(

j) delivery management site code for the immunization

preceding the adverse event following immunization, if

available.

(3) In addition to the information listed in subsection (2), a report

submitted by a regional health authority to the Chief Medical Officer

must refer to one or more of the following events:

(

a) an event listed in the

Schedule in item (a), (d), (g), (h), (j),

(k), (l), (o), (p), (q), (t), (u), (v), (aa) or (cc), only if

diagnosed by a physician;

(

b) an event listed in the

Schedule in item (b), (c), (e), (f), (i),

(m), (n), (r), (s), (w), (x), (y), (z), (bb) or (dd).

Part 3

Maintenance of Vaccine Viability

Interpretation

7 In this Part,

(a) "handle", in respect of vaccine, means to manipulate, in the

course of one's employment duties, a package of vaccine,

including, without limitation, for the purposes of preparing

the vaccine for transportation or for administration to a

patient;

(b) "vaccine" means a biological agent intended for use in

immunization.

Transportation requirements

8(1) A person who directs the transportation of a package of vaccine

shall provide instructions to the persons who have duties in the

transportation of the package of vaccine for the purpose of ensuring

that the temperature conditions, as specified in the monograph for the

vaccine posted on the Health Canada website, are complied with

during transportation.

(2) A person who accepts delivery of a transported package of vaccine

shall, immediately on delivery,

(

a) review the condition of the package of vaccine and make best

efforts to determine if the temperature conditions as specified

in the monograph for the vaccine, posted on the Health

Canada website, have been complied with during

transportation, and

(

b) ensure that, after the review, the vaccine is stored in

compliance with the temperature conditions as specified in

the monograph for the vaccine posted on the Health Canada

website.

Storage requirements

9(1) A person who directs or has employment duties respecting the

storage of vaccine shall ensure that the temperature conditions, as

specified in the monograph for the vaccine posted on the Health

Canada website, are complied with during storage.

(2) A person who directs the storage of vaccine shall ensure that the

temperature of the storage unit is monitored continuously by a method

that is capable of displaying or recording the minimum and maximum

temperatures in the storage unit for the purposes of compliance with

subsection (3).

(3) A person who directs the storage of vaccine shall ensure that, for

the days that the site of the storage operates or is open for business, the

maximum and minimum temperatures in the storage unit

(

a) are checked at least twice daily, and

(

b) are recorded in a log at least twice daily, to show the

maximum and minimum temperatures since the last

recording, with 2 of the recordings for each day being

separated by at least 8 hours.

(4) A person who directs the storage of vaccine shall retain a

recording referred to in subsection (3) for at least one year after the

recording is made.

Handling requirements

10 A person who handles vaccine shall ensure that the temperature

conditions, as specified in the monograph for the vaccine posted on the

Health Canada website, are complied with during handling.

Action following contravention of

temperature conditions

11 A person having employment duties respecting the storage,

handling or transportation of vaccine who determines or becomes

aware that the temperature conditions, as specified in the monograph

for the vaccine posted on the Health Canada website, have been

contravened shall, as soon as possible,

(

a) quarantine the vaccine from other vaccines to prevent it from

being administered,

(

b) clearly mark the vaccine as quarantined and not to be used

for immunization,

(

c) ensure that the vaccine is stored under the temperature

conditions, as specified in the monograph for the vaccine

posted on the Health Canada website, and

(

d) notify a health practitioner who has responsibility for action

after a quarantine.

Action after quarantine

12(1) A health practitioner who is notified under

section 11(

d) or

otherwise becomes aware of a contravention of the temperature

conditions, as specified in the monograph for the vaccine posted on the

Health Canada website, shall, as soon as possible and no later than 5

days after being notified or becoming aware, contact the manufacturer

of the vaccine to request a viability assessment and determination

respecting that vaccine.

(2) The health practitioner shall ensure that vaccine determined by the

manufacturer to be non-viable is not administered to a patient and is

disposed of or returned to the manufacturer.

(3) If the manufacturer determines that the vaccine is non-viable, and

the vaccine was administered to a patient, the health practitioner shall,

as soon as possible and no later than 5 days after the manufacturer's

notification of non-viability, ensure that the delivery management site

at which the vaccine was administered is notified of the non-viability.

(4) Within 5 days after a notification of the non-viability of a vaccine

under subsection (3), a designated health practitioner at the delivery

management site shall make reasonable attempts to notify all patients

who were administered the non-viable vaccine.

(5) Vaccine that has been determined by the manufacturer after an

assessment requested under subsection (1) to be viable may be

removed from quarantine and administered to a patient.

Record keeping re temperature

conditions contravention

13(1) A person referred to in

section 11 or 12(1) shall ensure that the

following information is recorded:

(

a) the date and time that the temperature conditions

contravention was identified (format: 2018July24, 0900);

(

b) the date and time the vaccine was quarantined (format:

2018July24, 1000);

(

c) the maximum and minimum temperatures recorded during

the temperature conditions contravention (for example,

-4øC and +22øC);

(

d) the duration of the contravention or the maximum possible

duration if the actual duration is unknown (for example,

approximately 22 hours);

(

e) the date that the viability assessment and determination were

provided (format: 2018July25);

(

f) the vaccine viability determination (that is, viable or

non-viable);

(

g) a statement of whether any non-viable vaccines were

administered to patients;

(

h) the vaccine code of the vaccine that was exposed to

conditions contravening the temperature conditions;

(

i) the manufacturer of the vaccine that was exposed to

conditions contravening the temperature conditions;

(

j) the lot number of the vaccine that was exposed to conditions

contravening the temperature conditions.

(2) The person referred to in

section 11 or 12(1) shall ensure that a

copy of the information recorded under subsection (1)(a), (c), (

d) and

(

f) is kept with the vaccine that is determined by the manufacturer to

be viable.

(3) The information recorded under subsection (1) must be retained

for at least 7 years.

Coming into force

14(1) This Regulation, except sections 2, 3 and 4, comes into force on

the coming into force of

section 23(a)(ii) and (

b) of the Public Health

Amendment Act, 2016.

(2) Sections 2, 3 and 4 come into force on January 1, 2021.

Schedule

Adverse Event Following Immunization to be

Reported by a Regional Health Authority

(

a) acute disseminated encephalomyelitis;

(

b) adenopathy;

(

c) allergic reaction;

(

d) anaesthesia or paraesthesia;

(

e) anaphylaxis;

(

f) arthralgia or arthritis;

(

g) Bell's palsy;

(

h) cellulitis;

(

i) convulsion (febrile or afebrile);

(

j) encephalitis;

(

k) erythema multiforme;

(

l) Guillain-Barr‚ syndrome;

(

m) hypotonic-hyporesponsive episode (HHE);

(

n) infected abscess;

(

o) intussusception;

(

p) meningitis;

(

q) myelitis;

(

r) nodule;

(

s) oculo-respiratory syndrome (ORS);

(

t) orchitis;

(

u) paralysis;

(

v) parotitis;

(

w) rash;

(

x) screaming episode or persistent crying;

(

y) severe diarrhea or vomiting;

(

z) sterile abscess;

(aa) subacute sclerosing panencephalitis;

(bb) swelling or pain;

(cc) thrombocytopenia;

(dd) other severe or unusual events.

--------------------------------

Alberta Regulation 183/2018

Government Organization Act

UTILITIES CONSUMER ADVOCATE REGULATION

Filed: October 18, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 308/2018)

on October 17, 2018 pursuant to

Schedule 13.1,

section 3 of the Government

Organization Act.

Definition

1(1) In this Regulation, "Schedule" means

Schedule 13.1 to the

Government Organization Act.

Collection and disclosure of consumer information

2(1) The Office of the Utilities Consumer Advocate may collect, use

and disclose information, including a consumer's personal information,

for the purposes of carrying out the responsibilities set out in

section

3(

e) and (

f) of the Schedule.

(2) A collection or disclosure of information referred to in this

section

may occur indirectly, without the consent of the consumer.

(3) For the purposes set out in subsection (1), the Office of the

Utilities Consumer Advocate is authorized to collect and use

information, including personal information about a consumer, from

(

a) a distributor,

(

c) the Market Surveillance Administrator,

(

d) an organization as defined in the Personal Information

Protection Act,

(

e) a provider,

(

f) a public body as defined in the Freedom of Information and

Protection of Privacy Act,

(

g) a retailer, and

(

h) any other persons as reasonably required to carry out the

responsibilities set out in

section 3(

e) and (

f) of the Schedule.

(4) For the purposes set out in subsection (1), the bodies,

organizations and persons referred to in subsection (3) are authorized

to disclose information, including personal information about a

consumer, to the Office of the Utilities Consumer Advocate.

(5) For the purposes set out in subsection (1), the Office of the

Utilities Consumer Advocate is authorized to disclose information

collected under this section, including personal information about a

consumer, to

(

a) a distributor,

(

c) the Market Surveillance Administrator,

(

d) an organization as defined in the Personal Information

Protection Act,

(

e) a provider,

(

f) a public body as defined in the Freedom of Information and

Protection of Privacy Act,

(

g) a retailer, and

(

h) any other persons as reasonably required to carry out the

responsibilities set out in

section 3(

e) and (

f) of the Schedule.

Repeal

3 The Utilities Consumer Advocate Regulation (AR 190/2014) is

repealed.

Coming into force

4 This Regulation comes into force on the coming into force of An

Act to Empower Utility Consumers.

Alberta Regulation 184/2018

Travel Alberta Act

TRAVEL ALBERTA GENERAL AMENDMENT REGULATION

Filed: October 18, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 309/2018)

on October 17, 2018 pursuant to

section 16 of the Travel Alberta Act.

1 The Travel Alberta General Regulation (AR 48/2009) is

amended by this Regulation.

Section 2.1(2) is repealed.

Section 3 is repealed.

Section 4(2) is repealed and the following is substituted:

(2) The Corporation must ensure that the Corporation has

appropriate liability insurance to indemnify the Corporation

against the costs, charges and expenses in respect of which

indemnification under

section 11(1) of the Act may be required.

Section 5 is repealed.

--------------------------------

Alberta Regulation 185/2018

Municipal Government Act

MATTERS RELATING TO ASSESSMENT AND TAXATION,

2018 AMENDMENT REGULATION

Filed: Filed October 29, 2018

For information only: Made by the Minister of Municipal Affairs (M.O. MAG:017/18)

on October 17, 2018 pursuant to sections 322 and 370 of the Municipal Government Act.

1 The Matters Relating to Assessment and Taxation

Regulation, 2018 (AR 203/2017) is amended by this

Regulation.

Section 20(3) is amended in the formula by striking out

"Assessments for residential property" and substituting

"Assessments for non-residential property"

--------------------------------

Alberta Regulation 186/2018

Safety Codes Act

ELECTRICAL CODE AMENDMENT REGULATION

Filed: October 31, 2018

For information only: Made by the Lieutenant Governor in Council (O.C. 319/2018)

on October 30, 2018 pursuant to

section 65 of the Safety Codes Act.

1 The Electrical Code Regulation (AR 209/2006) is

amended by this Regulation.

Section 3 is repealed and the following is substituted:

Codes declared in force

3 The following codes, as amended or replaced from time to time,

are declared in force in respect of electrical systems:

(

a) the CSA Standard C22.1-18 - 2018 Canadian Electrical

Code,

Part 1 (24th edition), Safety Standard for Electrical

Installations, published by the CSA Group;

(

b) the Alberta Electrical Utility Code - 5th Edition, April 2016,

published by the Safety Codes Council.

3 This Regulation comes into force on February 1, 2019.